Zobrazeno 1 - 10
of 864
pro vyhledávání: '"Maria Vidal"'
Autor:
Natàlia Lorman-Carbó, Olga Martínez-Sáez, Aranzazu Fernandez-Martinez, Patricia Galván, Nuria Chic, Isabel Garcia-Fructuoso, Adela Rodríguez, Raquel Gómez-Bravo, Francesco Schettini, Paula Blasco, Oleguer Castillo, Blanca González-Farré, Barbara Adamo, Maria Vidal, Montserrat Muñoz, Charles M. Perou, Marcos Malumbres, Joaquín Gavilá, Tomás Pascual, Aleix Prat, Fara Brasó-Maristany
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract This study examines the biological effects of palbociclib and ribociclib in hormone receptor-positive breast cancer, pivotal to the HARMONIA prospective phase III clinical trial. We explore the downstream impacts of these CDK4/6 inhibitors,
Externí odkaz:
https://doaj.org/article/ea86ec3e16194f1f8bdd3ad02a335dd9
Autor:
Fara Brasó-Maristany, Juan Manuel Ferrero-Cafiero, Claudette Falato, Olga Martínez-Sáez, Juan Miguel Cejalvo, Mireia Margelí, Pablo Tolosa, Francisco Javier Salvador-Bofill, Josefina Cruz, Blanca González-Farré, Esther Sanfeliu, Andreu Òdena, Violeta Serra, Francisco Pardo, Ana María Luna Barrera, Miriam Arumi, Juan Antonio Guerra, Guillermo Villacampa, Rodrigo Sánchez-Bayona, Eva Ciruelos, Martín Espinosa-Bravo, Yann Izarzugaza, Patricia Galván, Judith Matito, Sonia Pernas, Maria Vidal, Anu Santhanagopal, Dalila Sellami, Stephen Esker, Pang-Dian Fan, Fumitaka Suto, Ana Vivancos, Tomás Pascual, Aleix Prat, Mafalda Oliveira
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-13 (2024)
Abstract Patritumab deruxtecan (HER3-DXd) exhibits promising efficacy in breast cancer, with its activity not directly correlated to baseline ERBB3/HER3 levels. This research investigates the genetic factors affecting HER3-DXd’s response in women w
Externí odkaz:
https://doaj.org/article/7c7d4486147e4021ad5651e0e2b54a88
Autor:
Anna Ruiz-Mitjana, Maria Vidal-Sabanés, Raúl Navaridas, Aida Perramon-Güell, Andree Yeramian, Nathan Nicholson-Sabaté, Joaquim Egea, Mario Encinas, Xavier Matias-Guiu, Xavier Dolcet
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 168, Iss , Pp 115817- (2023)
Metformin is a widespread antidiabetic agent that is commonly used as a treatment against type 2 diabetes mellitus patients. Regarding its therapeutic potential, multiple studies have concluded that Metformin exhibits antineoplastic activity on sever
Externí odkaz:
https://doaj.org/article/7084576a9a2e456c843b6208f523947c
Autor:
Raúl Navaridas, Maria Vidal‐Sabanés, Anna Ruiz‐Mitjana, Gisela Altés, Aida Perramon‐Güell, Andree Yeramian, Joaquim Egea, Mario Encinas, Sonia Gatius, Xavier Matias‐Guiu, Xavier Dolcet
Publikováno v:
Advanced Science, Vol 10, Iss 32, Pp n/a-n/a (2023)
Abstract Phosphatase and TENsin homolog (Pten) and p53 are two of the most frequently mutated tumor suppressor genes in endometrial cancer. However, the functional consequences and histopathological manifestation of concomitant p53 and Pten loss of f
Externí odkaz:
https://doaj.org/article/a10e9bdc8afb41bba8c8fa70ed603e4f
Autor:
Raúl Navaridas, Maria Vidal‐Sabanés, Anna Ruiz‐Mitjana, Aida Perramon‐Güell, Cristina Megino‐Luque, David Llobet‐Navas, Xavier Matias‐Guiu, Joaquim Egea, Mario Encinas, Lídia Bardia, Julien Colombelli, Xavier Dolcet
Publikováno v:
Cancer Communications, Vol 43, Iss 5, Pp 620-624 (2023)
Externí odkaz:
https://doaj.org/article/07b55548b70041ffb7bc3d9db626bcb2
Autor:
Beatriz Ocaña-Tienda, Julián Pérez-Beteta, José D. Villanueva-García, José A. Romero-Rosales, David Molina-García, Yannick Suter, Beatriz Asenjo, David Albillo, Ana Ortiz de Mendivil, Luis A. Pérez-Romasanta, Elisabet González-Del Portillo, Manuel Llorente, Natalia Carballo, Fátima Nagib-Raya, Maria Vidal-Denis, Belén Luque, Mauricio Reyes, Estanislao Arana, Víctor M. Pérez-García
Publikováno v:
Scientific Data, Vol 10, Iss 1, Pp 1-6 (2023)
Abstract Brain metastasis (BM) is one of the main complications of many cancers, and the most frequent malignancy of the central nervous system. Imaging studies of BMs are routinely used for diagnosis of disease, treatment planning and follow-up. Art
Externí odkaz:
https://doaj.org/article/3bf38b90c0d541ebb693fa2533acc1aa
Autor:
Aleix Prat, Fara Brasó-Maristany, Olga Martínez-Sáez, Esther Sanfeliu, Youli Xia, Meritxell Bellet, Patricia Galván, Débora Martínez, Tomás Pascual, Mercedes Marín-Aguilera, Anna Rodríguez, Nuria Chic, Barbara Adamo, Laia Paré, Maria Vidal, Mireia Margelí, Ester Ballana, Marina Gómez-Rey, Mafalda Oliveira, Eudald Felip, Judit Matito, Rodrigo Sánchez-Bayona, Anna Suñol, Cristina Saura, Eva Ciruelos, Pablo Tolosa, Montserrat Muñoz, Blanca González-Farré, Patricia Villagrasa, Joel S. Parker, Charles M. Perou, Ana Vivancos
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-16 (2023)
Plasma ctDNA is a promising method to determine patient outcome in multiple cancer types. Here, the authors use shallow WGS to create machine learning signatures to identify tumor phenotypes and predict therapy response in patients with metastatic br
Externí odkaz:
https://doaj.org/article/3f12bbd8bddf4a1d9f66456aec50f23c
Autor:
Javier Salvador Bofill, Fernando Moreno Anton, Cesar Augusto Rodriguez Sanchez, Elena Galve Calvo, Cristina Hernando Melia, Eva Maria Ciruelos Gil, Maria Vidal, Begoña Jiménez-Rodriguez, Luis De la Cruz Merino, Noelia Martínez Jañez, Rafael Villanueva Vazquez, Ruben de Toro Salas, Antonio Anton Torres, Isabel Manuela Alvarez Lopez, Joaquin Gavila Gregori, Vanesa Quiroga Garcia, Elena Vicente Rubio, Juan De la Haba-Rodriguez, Santiago Gonzalez-Santiago, Nieves Diaz Fernandez, Agusti Barnadas Molins, Blanca Cantos Sanchez de Ibargüen, Juan Ignacio Delgado Mingorance, Meritxell Bellet Ezquerra, Sonia de Casa, Asuncion Gimeno, Miguel Martin
Publikováno v:
Breast, Vol 66, Iss , Pp 77-84 (2022)
Background: Breast cancer is the most common malignancy and the second leading cause of cancer-related mortality in Spanish women. Ribociclib in combination with endocrine therapy (ET) has shown superiority in prolonging survival in patients with hor
Externí odkaz:
https://doaj.org/article/dad241cf2af94fb9adb70457754b6c11
Publikováno v:
REC: Interventional Cardiology, Vol 5, Iss 1, Pp 71-73 (2023)
Sr. Editor: Presentamos el caso de un varón joven con una gran comunicación interventricular (CIV) postinfarto que se reparó quirúrgicamente de forma diferida tras 10 días de soporte con circulación con oxigenador extracorpóreo de membrana ven
Externí odkaz:
https://doaj.org/article/f26d73b1333c4138bec1322dbbc17f4e
Publikováno v:
REC: Interventional Cardiology (English Ed.), Vol 5, Iss 1, Pp 71-73 (2023)
To the Editor, This is the case of a young man with a postmyocardial infarction large ventricular septal defect (VSD) surgically repaired 10 days after venoarterial extracorporeal membrane oxygenation (VA-ECMO) therapy. The patient still had a large
Externí odkaz:
https://doaj.org/article/9b35e11443eb4677a434b7b0855a174d